Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
20
Share
QR code
Edit Profile
Jennifer Seminerio- Diehl
Assistant Professor
INTERNAL MEDICINE | MORSANI COLLEGE OF MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Background
Publications
Co-Investigator Network
Websites
Contact
All
Research
Background
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Internal Medicine
Research Projects
Ends
Title
01-2029
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn¿s Disease
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn¿s Disease
07-2028
A Phase 3, Mullicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
A Phase 3, Mullicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
07-2028
A Phase 3, Multicenter, Randomized, Double-blind, Placebo--controlled Study of Oral Ozanlmod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-blind, Placebo--controlled Study of Oral Ozanlmod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
07-2028
Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn¿s Disease
Induction Study #2 - A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn¿s Disease
05-2026
A Phase 3, Multicenter, Open-Label, Long-Term Extension
A Phase 3, Multicenter, Open-Label, Long-Term Extension
06-2025
Protocol #TOUR
Protocol #TOUR
01-2024
A Multicenter, Randomized, Double Blind, Parallel Group
A Multicenter, Randomized, Double Blind, Parallel Group
11-2023
Protocol #IBD-600
Protocol #IBD-600
11-2023
A Randomized, Double Blind, Placebo Controlled, 52 Week
A Randomized, Double Blind, Placebo Controlled, 52 Week
11-2023
A Phase 3, Multicenter, Randomized, Efficacy Assessor-Bl
A Phase 3, Multicenter, Randomized, Efficacy Assessor-Bl
02-2023
Protocol #I6T-MC-AMAM
Protocol #I6T-MC-AMAM
01-2023
Protocol #APD334-302
Protocol #APD334-302
05-2022
Protocol #P11-282
Protocol #P11-282
02-2022
Protocol #APD334-303
Protocol #APD334-303
02-2022
Protocol #APD334-301
Protocol #APD334-301
12-2021
Florida IBD Live
Florida IBD Live
Degrees
MD, Doctor of Medicine
University of Toledo College of Medicine ▪ 2008
Publications
Search Google Scholar for Jennifer Seminerio- Diehl
Co-Investigator Network
Inactive Expert
Renee Marchioni Beery
Assistant Professor
University of South Florida
Internal Medicine, Morsani College Of Medicine
renee41@usf.edu
Websites
Search Google Scholar for Jennifer Seminerio- Diehl
twitter
linkedIn
facebook
Contact Information
jenniferlsem@usf.edu
(813) 974-2011
University of South Florida 4202 E. Fowler Avenue Tampa, FL 33620
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
